The Patent Finder

Laurel Therapeutics Ltd.

Also on record
Records under this name other than the patents Laurel Therapeutics Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 10 of 10 · Back to Laurel Therapeutics Ltd.

PatentTitleStatus Expires Confidence
US 8,673,961Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Lapsed on the fee record
Ended Mar 18, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2026From the USPTO record
US 9,856,219Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
Lapsed on the fee record
Ended Jan 2, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 2, 2026From the USPTO record
US 9,814,700Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Lapsed on the fee record
Ended Nov 14, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 14, 2025From the USPTO record
US 9,498,466Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Lapsed on the fee record
Ended Nov 22, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 22, 2024From the USPTO record
US 9,433,618Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
Lapsed on the fee record
Ended Sep 6, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 6, 2024From the USPTO record
US 9,315,462Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
Lapsed on the fee record
Ended Apr 19, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 19, 2024From the USPTO record
US 9,180,119Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Lapsed on the fee record
Ended Nov 10, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 10, 2023From the USPTO record
US 9,139,528Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
Lapsed on the fee record
Ended Sep 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 22, 2023From the USPTO record
US 10,399,946Solid forms of an S-Nitrosoglutathione reductase inhibitor
Lapsed on the fee record
Ended Sep 3, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 3, 2023From the USPTO record
US 8,957,105Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Lapsed on the fee record
Ended Feb 17, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 17, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited